187 related articles for article (PubMed ID: 16125539)
1. Combined corticotropin-releasing hormone and glucocorticoid deficiency does not enhance counterregulatory responses after recurrent hypoglycemia in mice.
Jacobson L; Pacák K
Metabolism; 2005 Sep; 54(9):1259-65. PubMed ID: 16125539
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia.
Jacobson L; Ansari T; Potts J; McGuinness OP
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E15-22. PubMed ID: 16449297
[TBL] [Abstract][Full Text] [Related]
3. CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors.
Jacobson L; Muglia LJ; Weninger SC; Pacák K; Majzoub JA
Neuroendocrinology; 2000 Feb; 71(2):79-87. PubMed ID: 10686522
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin treatment without and with recurrent hypoglycemia on hypoglycemic counterregulation and adrenal catecholamine-synthesizing enzymes in diabetic rats.
Inouye KE; Yue JT; Chan O; Kim T; Akirav EM; Park E; Riddell MC; Burdett E; Matthews SG; Vranic M
Endocrinology; 2006 Apr; 147(4):1860-70. PubMed ID: 16396986
[TBL] [Abstract][Full Text] [Related]
5. Lower weight loss and food intake in protein-deprived, corticotropin releasing hormone-deficient mice correlate with glucocorticoid insufficiency.
Jacobson L
Endocrinology; 1999 Aug; 140(8):3543-51. PubMed ID: 10433210
[TBL] [Abstract][Full Text] [Related]
6. Impaired basal and restraint-induced epinephrine secretion in corticotropin-releasing hormone-deficient mice.
Jeong KH; Jacobson L; Pacák K; Widmaier EP; Goldstein DS; Majzoub JA
Endocrinology; 2000 Mar; 141(3):1142-50. PubMed ID: 10698191
[TBL] [Abstract][Full Text] [Related]
7. Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia.
Flanagan DE; Keshavarz T; Evans ML; Flanagan S; Fan X; Jacob RJ; Sherwin RS
Diabetes; 2003 Mar; 52(3):605-13. PubMed ID: 12606499
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice.
Shankar K; Varshney S; Gupta D; Mani BK; Osborne-Lawrence S; Metzger NP; Richard CP; Zigman JM
Front Endocrinol (Lausanne); 2023; 14():1181856. PubMed ID: 37334290
[TBL] [Abstract][Full Text] [Related]
9. Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.
Jacobson L; Ansari T; McGuinness OP
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E678-84. PubMed ID: 16533951
[TBL] [Abstract][Full Text] [Related]
10. Role of CRH in glucopenia-induced adrenomedullary activation in rats.
Goldstein DS; Garty M; Bagdy G; Szemeredi K; Sternberg EM; Listwak S; Pacak K; Deka-Starosta A; Hoffman A; Chang PC
J Neuroendocrinol; 1993 Oct; 5(5):475-86. PubMed ID: 8680414
[TBL] [Abstract][Full Text] [Related]
11. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
12. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
13. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
[TBL] [Abstract][Full Text] [Related]
14. Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia.
Warner SO; Wadian AM; Smith M; Farmer B; Dai Y; Sheanon N; Edgerton DS; Winnick JJ
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E914-E924. PubMed ID: 33779306
[TBL] [Abstract][Full Text] [Related]
15. Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans.
Heptulla RA; Tamborlane WV; Ma TY; Rife F; Sherwin RS
J Clin Endocrinol Metab; 2001 Feb; 86(2):645-8. PubMed ID: 11158023
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral plasma corticotropin-releasing hormone (CRH) in an aged patient with fasting hypoglycemia associated with an insufficient secretion of insulin: an implication of plasma CRH in glucose metabolism].
Suemaru S; Suemaru K; Nishioka T; Hashimoto K
Nihon Naibunpi Gakkai Zasshi; 1995 Jul; 71(5):659-72. PubMed ID: 7556777
[TBL] [Abstract][Full Text] [Related]
17. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
Kale AY; Paranjape SA; Briski KP
Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
[TBL] [Abstract][Full Text] [Related]
18. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma.
Schöfl C; Schleth A; Berger D; Terkamp C; von zur Mühlen A; Brabant G
J Clin Endocrinol Metab; 2002 Feb; 87(2):624-9. PubMed ID: 11836295
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice.
Tooke BP; Yu H; Adams JM; Jones GL; Sutton-Kennedy T; Mundada L; Qi NR; Low MJ; Chhabra KH
Mol Metab; 2019 Feb; 20():194-204. PubMed ID: 30503832
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
Makino S; Smith MA; Gold PW
Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
